Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Feb;64(619):e75-80.
doi: 10.3399/bjgp14X677121.

Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups

Michael Moore  1 , Beth Stuart, Samuel Coenen, Chris C Butler, Herman Goossens, Theo J M Verheij, Paul Little; GRACE consortium
Collaborators, Affiliations
Randomized Controlled Trial

Amoxicillin for acute lower respiratory tract infection in primary care: subgroup analysis of potential high-risk groups

Michael Moore et al. Br J Gen Pract. 2014 Feb.

Erratum in

  • Br J Gen Pract. 2014 Mar;64(620):126

Abstract

Background: Antibiotics are of limited overall clinical benefit for uncomplicated lower respiratory tract infection (LRTI) but there is uncertainty about their effectiveness for patients with features associated with higher levels of antibiotic prescribing.

Aim: To estimate the benefits and harms of antibiotics for acute LRTI among those producing coloured sputum, smokers, those with fever or prior comorbidities, and longer duration of prior illness.

Design and setting: Secondary analysis of a randomised controlled trial of antibiotic placebo for acute LRTI in primary care.

Method: Two thousand and sixty-one adults with acute LRTI, where pneumonia was not suspected clinically, were given amoxicillin or matching placebo. The duration of symptoms, rated moderately bad or worse (primary outcome), symptom severity on days 2-4 (0-6 scale), and the development of new or worsening symptoms were analysed in pre-specified subgroups of interest. Evidence of differential treatment effectiveness was assessed in prespecified subgroups by interaction terms.

Results: No subgroups were identified that were significantly more likely to benefit from antibiotics in terms of symptom duration or the development of new or worsening symptoms. Those with a history of significant comorbidities experienced a significantly greater reduction in symptom severity between days 2 and 4 (interaction term -0.28, P = 0.003; estimated effect of antibiotics among those with a past history -0.28 [95% confidence interval = -0.44 to -0.11], P = 0.001), equivalent to three people in 10 rating symptoms as a slight rather than a moderately bad problem. For subgroups not specified in advance antibiotics provided a modest reduction in symptom severity for non-smokers and for those with short prior illness duration (<7 days), and a modest reduction in symptom duration for those with short prior illness duration.

Conclusion: There is no clear evidence of clinically meaningful benefit from antibiotics in the studied high-risk groups of patients presenting in general practice with uncomplicated LRTIs where prescribing is highest. Any possible benefit must be balanced against the side-effects and longer-term effects on antibiotic resistance.

Keywords: antibiotics; primary health care; randomised controlled trial; respiratory infections.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan–Meier survival curve for the duration of symptoms rated moderately bad or worse in patients with green sputum.
See this image and copyright information in PMC

Comment in

References

    1. Butler CC, Hood K, Verheij T, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ. 2009;338:b2242. - PMC - PubMed
    1. Butler CC, Hood K, Kelly MJ, et al. Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care. J Antimicrob Chemother. 2010;65(11):2472–2478. - PubMed
    1. Petersen I, Johnson AM, Islam A, et al. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ. 2007;335(7627):982. - PMC - PubMed
    1. Akkerman AE, van der Wouden JC, Kuyvenhoven MM, et al. Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother. 2004;54(6):1116–1121. - PubMed
    1. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Emerg Med. 2001;37(6):720–727. - PMC - PubMed

Publication types

MeSH terms

Associated data